Equator Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Early Stage VC
- Investors
-
10
Equator Therapeutics General Information
Description
Developer of novel drugs designed to burn calories and improve metabolism. The company is developing drugs that activate the protein that mitochondria naturally use to produce heat, as well as developing a platform to identify compounds that selectively activate this target protein, without side effects, enabling consumers to reduce obesity.
Contact Information
Website
www.equatortherapeutics.comCorporate Office
- 4340 Duncan Avenue
- Suite 210
- Saint Louis, MO 63110
- United States
Corporate Office
- 4340 Duncan Avenue
- Suite 210
- Saint Louis, MO 63110
- United States
Equator Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Early Stage VC | 01-Jan-2024 | Completed | Startup | |||
| 8. Early Stage VC | 01-Jan-2023 | Completed | Startup | |||
| 7. Secondary Transaction - Private | 01-Nov-2022 | Completed | Startup | |||
| 6. Early Stage VC | 01-Jan-2022 | Completed | Startup | |||
| 5. Seed Round | 01-Dec-2021 | Completed | Startup | |||
| 4. Grant | 20-Sep-2021 | Completed | Startup | |||
| 3. Seed Round | 01-Jun-2021 | Completed | Startup | |||
| 2. Accelerator/Incubator | 18-Mar-2020 | $125K | $125K | Completed | Startup | |
| 1. Seed Round | 01-Mar-2020 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Equator Therapeutics Patents
Equator Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026060261-A1 | Compositions and methods for treating metabolic disorders | Pending | 13-Sep-2024 | ||
| AU-2025235503-A1 | Compositions and methods for treating metabolic disorders | Pending | 11-Mar-2024 | ||
| WO-2025193697-A1 | Compositions and methods for treating metabolic disorders | Pending | 11-Mar-2024 | A61K31/433 |
Equator Therapeutics Signals
Equator Therapeutics Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioGenerator Ventures | Venture Capital | Minority | ||
| Thoobik Holdings | Venture Capital | Minority | ||
| Healthspan Capital | Venture Capital | Minority | ||
| Endurance28 | Venture Capital | Minority | ||
| Evolution VC Partners | Venture Capital | Minority |
Equator Therapeutics FAQs
-
When was Equator Therapeutics founded?
Equator Therapeutics was founded in 2019.
-
Where is Equator Therapeutics headquartered?
Equator Therapeutics is headquartered in Saint Louis, MO.
-
What is the size of Equator Therapeutics?
Equator Therapeutics has 6 total employees.
-
What industry is Equator Therapeutics in?
Equator Therapeutics’s primary industry is Drug Discovery.
-
Is Equator Therapeutics a private or public company?
Equator Therapeutics is a Private company.
-
What is Equator Therapeutics’s current revenue?
The current revenue for Equator Therapeutics is .
-
How much funding has Equator Therapeutics raised over time?
Equator Therapeutics has raised $125K.
-
Who are Equator Therapeutics’s investors?
BioGenerator Ventures, Thoobik Holdings, Healthspan Capital, Endurance28, and Evolution VC Partners are 5 of 10 investors who have invested in Equator Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process